跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,631 条关于
“TLR-MD2”
全部
4,631
临床试验
3,179
药物
988
机构
77
资讯
387
去年
Vyome's VT-1953 Demonstrates Significant Efficacy in Phase 2 Trial for Malignant Fungating Wounds
去年
Vyome Therapeutics' VT-1953 Shows Promise in Phase 2 Trial for Malignant Fungating Wounds
去年
Empyrean Therapeutics Acquires TLR-2 Antagonist EMS-312 from Eos Therapies to Advance Cancer Treatment
6个月前
Kupando Raises €10 Million to Advance Dual TLR Agonist KUP101 into Phase 1b Clinical Trial
2年前
OCT-Guided PCI Improves Outcomes in Complex Coronary Lesions: OCCUPI Trial
7个月前
Primmune Therapeutics Raises $8.6M to Advance TLR7 Agonist PRTX007 into Phase 2 Melanoma Trial
2个月前
SirPAD: Sirolimus-Coated Balloons Cut Amputation and Revascularization in Infrainguinal PAD
去年
SELUTION SLR Drug-Eluting Balloon Shows Exceptional 3-Year Patency Rates in Peripheral Artery Disease Trials
8个月前
Eikon Therapeutics Files for $100 Million IPO to Advance Late-Stage Cancer Pipeline
去年
Emavusertib-Based Therapy Shows Promise in BTK Inhibitor-Refractory PCNSL
第 1 页,共 39 页
上一页
下一页